Company intelligence / Profile preview

JC (Wuxi)

Wuxi, Jiangsu, China

Ownership: Private
Development stage: Other

Overview

JC Biopharma, specifically JC (Wuxi) Biopharmaceutical Co., Ltd., is a contract development and manufacturing organization (CDMO) based in Wuxi, China, specializing in biologics. The company provides a comprehensive suite of services ranging from cell line development and process optimization to large-scale GMP manufacturing of recombinant proteins and monoclonal antibodies. JC Biopharma leverages advanced mammalian cell culture technologies to support global pharmaceutical and biotechnology partners in accelerating their drug development timelines. Their facilities are designed to meet international regulatory standards, facilitating the production of high-quality clinical and commercial-grade biopharmaceuticals.

Modalities: Monoclonal antibodyRecombinant proteinBispecific monoclonal antibody
Industry: Drug Discovery Services

Beyond the preview

Go deeper on JC (Wuxi).

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on JC (Wuxi).

Explore the full profile